Antibody tests might be deceptively dangerous. Blame the math.

It is hard to make money treating rare diseases. There simply aren’t enough customers to generate many profits. That’s why the U.S. government passed the Orphan Drug Act in 1983, a law which created a series of incentives to encourage drug companies to develop treatments for rare or “orphan” diseases – conditions affecting less than…

Recently, I showed some data illustrating the rapid growth in healthcare jobs in the United States, compared to jobs in other parts of the economy. Here’s a picture, courtesy of Dan Diamond, showing that this growth has not been steady. Instead, the growth of hospital jobs in the US stalled for a while, before taking…